العربية
Welcome To Hama Pharma
Hama Pharma for Pharmaceutical Industries was established in Al-Salamiyah Street – Hama in 2011 .
Hama Pharma is one of the leading Syrian companies in the field of producing human medicines efficiently, high quality and at reasonable prices for most of the modern treatment groups needed by patients .
The production includes four lines for manufacturing pharmaceutical forms, a quality control department, and a scientific research and development department .
Production lines are equipped with the latest equipment manufactured according to the most accurate international, technological and laboratory standards that meet the requirements applied in the human pharmaceutical industry .
The average production capacity is around 35 million packages of finished pharmaceuticals annually .
The quality control and scientific research departments have been equipped with analytical and microbiological laboratories containing the most recent and important specialized equipment .
The production processes are carried out accuratly according to the requirements of labors protection and environmental protection by using advanced technology and modern equipment .
Among the manufactured medicines, cardiovascular medicines, antibacterial medicines, central sedatives, muscle relaxants, anti-ulcers and other medicines occupy an important place in the internal and external pharmaceutical market, where they are available in pharmaceutical forms and dosages that facilitate their use.
Our Strategic Vision
Driven by an ambitious national vision, Hama Pharma was established to lead the local pharmaceutical sector and elevate the therapeutic ecosystem toward achieving sustainable self-sufficiency. We firmly believe that providing locally manufactured medicines with world-class quality is, above all, a professional and humanitarian commitment. Grounded in this belief, we have formulated a production strategy capable of meeting the aspirations of the healthcare sector, delivering the most efficient pharmaceutical alternatives to both physicians and patients alike.
Future Goals and Global Outlook
Our aspirations at Hama Pharma extend far beyond responding to current needs; we are dedicated to establishing the prominent status of Syrian medicine and restoring its strong presence in regional and international markets. We strive to build solid strategic partnerships and foster global trust in our national industry as a primary and sustainable choice, thereby contributing to shaping a bright and secure future for the healthcare sector.
Strategic Pillars and Our Developmental Role
Hama Pharma operates according to well-studied plans and clear pillars aimed at strengthening the healthcare infrastructure through:
- Commitment to Good Manufacturing Practices (GMP): We adopt the latest technologies, software, and industrial systems to ensure that every pharmaceutical product is delivered with the highest levels of efficacy, safety, and reliability.
- Pharmaceutical Security and Overcoming Challenges: In light of economic and health crises, and to mitigate the impact of external sanctions imposed on the medical sector, we have taken upon ourselves the responsibility of filling gaps in the local market. This is achieved by supplying essential and life-saving pharmaceutical categories, replacing imports with local production.
- Sustainability and Continuous Development: Consistently investing in Research and Development (R&D) to expand our product portfolio and meet growing and emerging medical needs.
Clinical studies funded by Hama Pharma:
- Effect of melatonin analog (Agomelatine) therapy on improving the
tinnitus scale and sleep scale . - Rivaroxaban compared to warfarin for treatment of cerebral venous thrombosis : A randomized control trial .
Our slogan : Medicines that treat
Hama Pharma has obtained these certificates :
- Certificate of good laboratory practices GLP
- GMP Certification for Pharmaceutical Company
- OHSAS 18001:2007 (SAGACI)
- ISO 14001:2015 (SAGACI)
- ISO 9001:2015 (SAGACI)